Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Serum calcium was strongly and positively associated with circulating 25-OH-D (p = 0.006), whereas no significant association (p = 0.219) was found between calcium and PTH levels at the time of admission.Univariate and multivariate analysis of predictors for in-hospital death or ICU admission in all individuals (n = 111)Univariate analysisOR (95%CI)p valueMultivariate analysisaOR (95%CI)p valueAge (years)1.054 (1.021 to 1.088)0.001GenderFemale1 (ref)0.589Male0.800 (0.356 to 1.798)BMI (Kg/m2)1.037 (0.926 to 1.162)0.530Serum Calcium (mmol/L)0.382 (0.183 to 0.798)0.0100.444 (0.212 to 0.930)0.032Categories of initial serum calciumII-III tertile1 (ref)0.0071 (ref)0.016I tertile3.062 (1.365 to 6.869)2.828 (1.209 to 6.613)Serum Phosphorus (mmol/L)0.729 (0.461 to 1.153)0.176Serum Magnesium (mmol/L)0.611 (0.177 to 2.112)0.436PTH (ng/L)1.007 (0.997 to 1.018)0.19225-OH-vitamin D (ng/ml)0.878 (0.805 to 0.957)0.0030.892 (0.819 to 0.971)0.008Serum Creatinine (mg/dl)4.006 (1.010 to 15.889)0.0483.333 (0.762 to 14.584)0.110CRP (mg/L)1.010 (1.005 to 1.016)<0.0011.009 (1.003 to 1.015)0.002Procalcitonin (ng/ml)4.702 (1.221 to 18.105)0.0243.914 (1.071 to 14.307)0.039IL-6 (pg/ml)1.007 (1.000 to 1.013)0.0441.005 (0.999 to 1.012)0.109D-dimer (ng/ml)1.0000.308Fibrinogen (mg/dl)1.001 (0.999 to 1.003)0.183Time from symptoms onset to ER admission (days)0.886 (0.775 to 0.967)0.0110.904 (0.804 to 1.017)0.092HypertensionNo1 (ref)0.985Yes1.008 (0.453 to 2.244)Diabetes MellitusNo1 (ref)0.0401.717 (0.664 to 4.443)0.265Yes2.542 (1.046 to 6.177)Cardiovascular diseasesNo1 (ref)0.360Yes1.478 (0.640 to 3.412)COPDNo1 (ref)0.826Yes1.182 (0.267 to 5.244)Abbreviations as described in the textaAdjusted for age and genderCox regression analysis curves show significant difference in survival from in-hospital death (a) and severe COVID-19 (b) through days of hospitalization for patients stratified according to tertile categories of serum calcium at admission (tertile I vs tertile II + III)Scatterplotts of bivariate correlation analysis show significant inverse associations between serum calcium and inflammatory markers (CRP, IL-6, D-dimer) collected at admission
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Patients were classified as having cardiovascular diseases if coronary heart disease or arrhythmias or heart failure were present, according to reported medical history or ongoing medications.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Hypocalcemia is associated with adverse outcomes in patients hospitalized with COVID-19
Study design awaiting verification · Endocrine · 2022
Original publication title
Hypocalcemia is associated with adverse outcomes in patients hospitalized with COVID-19
© The Author(s) 2022
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Calcium ions are involved in the regulation of several cellular processes and may also influence viral replication. Hypocalcemia has been frequently reported during infectious diseases and in critically ill patients, including also COVID-19 patients, significantly related with the pro-inflammatory state and mortality. The aim of this study is to investigate the prevalence of hypocalcemia at admission in patients hospitalized for COVID-19 (Coronavirus disease 2019) and to evaluate association of hypocalcemia with in-hospital COVID-19 outcomes.
Source: PurposeAbstract: What methods does the paper describe?
Retrospective analysis on 118 consecutive patients, hospitalized for COVID-19 between March and May 2020. Clinical characteristics, inflammation markers, biochemical routine and mineral metabolism parameters at admission were collected. Hypocalcemia was defined as total serum calcium <2.2 mmol/L. Population was stratified by tertiles of total serum calcium. Primary outcome was the composite of in-hospital death or admission to intensive care unit (ICU). Secondary outcomes included in-hospital death, admission to ICU and need for non-invasive ventilation as separate events. Associations were tested by logistic regression and Cox-regression analysis with survival curves.
Source: MethodsAbstract: Results
Overall prevalence of hypocalcemia was 76.6%, with just 6.7% of patients reporting levels of 25-(OH)-vitamin D > 30 ng/ml. Total serum calcium was inversely related with selected inflammatory biomarkers (p < 0.05) and poorer outcome of COVID-19 during hospitalization. Lower tertile of total calcium (≤2.02 mmol/L) had increased risk of in-hospital mortality (HR 2.77; 1.28 to 6.03, p = 0.01) compared with other groups.
Source: ResultsAbstract: Conclusion
Total serum calcium detected on admission is inversely related with proinflammatory biomarkers of severe COVID-19 and is useful to better define risk stratification for adverse in-hospital outcome.
Source: ConclusionAuthors’ abstract
Purpose
Calcium ions are involved in the regulation of several cellular processes and may also influence viral replication. Hypocalcemia has been frequently reported during infectious diseases and in critically ill patients, including also COVID-19 patients, significantly related with the pro-inflammatory state and mortality. The aim of this study is to investigate the prevalence of hypocalcemia at admission in patients hospitalized for COVID-19 (Coronavirus disease 2019) and to evaluate association of hypocalcemia with in-hospital COVID-19 outcomes.
Methods
Retrospective analysis on 118 consecutive patients, hospitalized for COVID-19 between March and May 2020. Clinical characteristics, inflammation markers, biochemical routine and mineral metabolism parameters at admission were collected. Hypocalcemia was defined as total serum calcium <2.2 mmol/L. Population was stratified by tertiles of total serum calcium. Primary outcome was the composite of in-hospital death or admission to intensive care unit (ICU). Secondary outcomes included in-hospital death, admission to ICU and need for non-invasive ventilation as separate events. Associations were tested by logistic regression and Cox-regression analysis with survival curves.
Results
Overall prevalence of hypocalcemia was 76.6%, with just 6.7% of patients reporting levels of 25-(OH)-vitamin D > 30 ng/ml. Total serum calcium was inversely related with selected inflammatory biomarkers (p < 0.05) and poorer outcome of COVID-19 during hospitalization. Lower tertile of total calcium (≤2.02 mmol/L) had increased risk of in-hospital mortality (HR 2.77; 1.28 to 6.03, p = 0.01) compared with other groups.
Conclusion
Total serum calcium detected on admission is inversely related with proinflammatory biomarkers of severe COVID-19 and is useful to better define risk stratification for adverse in-hospital outcome.
Publication and source details
Original title: Hypocalcemia is associated with adverse outcomes in patients hospitalized with COVID-19
Alessandro Minasi; Aikaterini Andreadi; Alessio Maiorino; Luca Giudice; Sofia De Taddeo; Ilenia D’Ippolito; Ilaria de Guido; Rossella Laitano; Maria Romano; Valeria Ruotolo; Andrea Magrini; Nicola Di Daniele; Paola Rogliani; Alfonso Bellia; Davide Lauro
Endocrine · 2022
© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T07:43:39.264864+00:00
DOI: 10.1007/s12020-022-03239-w · PMC9643940